QA: Abbott Laboratories in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2013_Abbott_Laboratories.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0000001800, Abbott Laboratories

  xvar xval
0 AssetsCurrent 31,322,583,000
1 IntangibleAssetsNetIncludingGoodwill 24,362,412,000
2 PropertyPlantAndEquipmentNet 8,063,047,000
3 remainder_Assets 3,486,902,000
4 LiabilitiesCurrent 13,280,176,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,834,275,300
9 ResearchAndDevelopmentExpense 4,499,806,116
10 remainder_Expenses 15,964,533,585
11 remainder_Revenues 40,066,777,453
12 remainder_NetIncome -907,114,120
13 remainder_ComprehensiveNetIncome -1,033,849,970
  yvar yval
0 Assets 67,234,944,000
1 Liabilities 13,280,176,000
2 Expenses 32,298,615,001
3 Revenues 40,066,777,453
4 StockholdersEquity 53,954,768,000
5 NetIncome 6,861,048,332
6 ComprehensiveNetIncome 6,344,123,347
7 BaseVar 77,410,738,272
8 EconomicCapitalRatiobeforeLimitedLiability 3.08
9 EconomicCapitalRatio 3.74

Edgar->Model Mapping

Feature Distribution

Change over Time